Established in 2005, developing 505(b)2 New Drug to improve the quality of life of cancer patients who receive chemical and radiation therapy. More than 30 international patents were granted for this new application.
Oral and injectable generic drug development started in 2011, integrated with API capabilities. In 2019, the manufacturing facility was successfully inspected by both TFDA and FDA. With vertical integration ...
Established in 2005, developing 505(b)2 New Drug to improve the quality of life of cancer patients who receive chemical and radiation therapy. More than 30 international patents were granted for this new application.
Oral and injectable generic drug development started in 2011, integrated with API capabilities. In 2019, the manufacturing facility was successfully inspected by both TFDA and FDA. With vertical integration from API to finished Drug Product, our talents in chemistry, formulation, engineering, regulatory and project management have made Sunny a specialty pharma with international competitiveness.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.